The treatment of hookworm is essential not only for eliminating the parasites but also for reversing the debilitating effects of chronic infection—such as anaemia, malnutrition, and developmental delays. Timely and effective treatment greatly improves health outcomes, particularly for vulnerable groups like children, pregnant women, and those with poor nutritional status. Fortunately, treatment is generally straightforward, affordable, and widely available, though significant challenges remain in delivering care to high-risk populations.
Anthelmintic Medications: The First Line of Defense
The cornerstone of therapy involves anthelmintic medications, which specifically target parasitic worms. The two most commonly used drugs are:
- Albendazole (400 mg single oral dose)
- Mebendazole (500 mg single oral dose)
Both are broad-spectrum agents with proven efficacy against hookworm species such as Necator americanus and Ancylostoma duodenale. While a single dose is often sufficient for uncomplicated infections, a three-day course may be required in cases of heavy worm burden for more complete eradication.
These drugs work by disrupting the parasite’s glucose uptake, leading to energy depletion and eventual death. They are usually well tolerated, with only mild side effects such as abdominal discomfort, nausea, or dizziness. Albendazole is often preferred due to its slightly higher cure rates, although regional drug resistance patterns and patient compliance can influence effectiveness.
Treatment Considerations During Pregnancy
In pregnant women, treatment requires special caution. Although hookworm infection can significantly increase the risk of maternal anaemia and poor birth outcomes, albendazole and mebendazole are generally avoided in the first trimester because of potential foetal risk. However, from the second trimester onward, the World Health Organization (WHO) recommends a single-dose deworming regimen in endemic regions to reduce maternal and neonatal complications. Many public health programmes incorporate this as part of routine antenatal care.
Addressing Nutritional Deficiencies
The treatment of hookworm is not complete without tackling the nutritional deficits caused by chronic infection. Iron-deficiency anaemia is the most frequent complication, so therapy often includes:
- Oral iron supplements (e.g., ferrous sulphate)
- Intravenous iron for severe cases
- Folic acid and multivitamin support
These measures help restore haemoglobin levels and replenish iron stores. Importantly, iron therapy should continue for several weeks after deworming to ensure full recovery.
Dietary Support and Nutritional Rehabilitation
Dietary counselling is especially important for children and adolescents. Patients are encouraged to consume iron-rich foods such as lean meats, leafy greens, legumes, and fortified cereals. In resource-limited settings, nutritional supplements are often provided through school feeding programmes or aid distribution initiatives.
Children suffering from protein-energy malnutrition due to hookworm require additional interventions, including:
- High-protein nutritional formulas
- Calorie-dense therapeutic foods
- Close monitoring of growth parameters
Severely malnourished children may even need hospital-based refeeding protocols before standard treatment can begin.
Community-Wide Deworming and Public Health Strategies
Beyond individual treatment, community-wide deworming programmes are critical in areas where hookworm is endemic. These mass drug administration (MDA) campaigns typically target:
- School-aged children
- Women of reproductive age
- High-risk rural populations
Deworming is usually performed every 6–12 months without prior stool testing, as the benefits outweigh the risks. Research shows that such programmes significantly reduce worm burden, improve school attendance, and enhance cognitive development in children.
Hygiene, Sanitation, and Behaviour Change
While medication clears existing infections, reinfection remains a major challenge in endemic areas. Therefore, long-term success requires improved sanitation and hygiene education, such as:
- Wearing shoes to prevent skin contact with contaminated soil
- Building and maintaining latrines
- Treating human waste properly
- Promoting access to clean water
Combining these measures with health education in schools can foster lasting behavioural change and help break the cycle of transmission.
Advanced Therapies and Monitoring
In rare cases or regions where drug resistance is suspected, combination therapy—such as albendazole plus ivermectin—may be considered. However, these strategies are not yet standard for routine hookworm cases and are usually reserved for complex situations or research purposes.
Monitoring treatment efficacy is also essential. Public health authorities often conduct stool-based surveys to assess the prevalence and intensity of infection after deworming campaigns. Persistent or increasing infection rates may indicate the need for:
- Revised treatment regimens
- Improved sanitation measures
- Increased frequency of MDA
Summary
In summary, the treatment of hookworm requires a comprehensive, multi-pronged approach that combines:
- Effective anthelmintic drugs (albendazole or mebendazole)
- Nutritional rehabilitation (iron, vitamins, dietary support)
- Public health strategies (mass deworming, sanitation, education)
By addressing both the infection and its socio-economic context, we can reduce disease burden and improve community health outcomes. With coordinated global and local efforts, hookworm can be effectively controlled and its impact dramatically diminished.
